I[ntroduction]{.smallcaps} {#sec1-1}
==========================

Total hip arthroplasty (THA) is commonly used to recover joint structure and function. As a kind of surgical intervention and a form of programmed trauma, it can cause a variety of physiological changes, including increased stress hormones, various humoral mediators, and acute-phase proteins, such as C-reactive protein (CRP).\[[@ref1]\] Especially, the pro-inflammatory cytokines, such as interleukin-6 (IL-6),\[[@ref2][@ref3]\] tumor necrosis factor-α,\[[@ref4]\] and IL-1β,\[[@ref5]\] are considered important mediators of the pathological changes associated with surgery. They play an important role in controlling the immune system in inflammatory response. In many studies, IL-6 has been recognized as a major mediator of the acute-phase protein response and a marker of postoperative tissue trauma.\[[@ref1][@ref2]\]

THA is associated with a noteworthy inflammatory response. As reported by Larsson *et al*.,\[[@ref6]\] this response might last more than 6 weeks after surgery. Some researchers suggested that the inflammatory response might determine postoperative recovery and complications.\[[@ref7][@ref8]\] However, to our knowledge, there have been few reports on the relationship between inflammatory response and postoperative complication rate.

Thus, the aim of the present study was to investigate the early inflammatory response in the first few days after THA and to identify the relationship between inflammatory response and complication rate. Just like what had been done in previous studies, IL-6 and CRP were adopted as the markers of the inflammatory response because they elevated markedly and were easy to be detected in systemic circulation even after mild inflammation.\[[@ref2]\]

M[ethods]{.smallcaps} {#sec1-2}
=====================

Subjects {#sec2-1}
--------

The investigation was designed as a prospective, nonrandomized cohort study, with the approval of the clinical research committee of our hospital. Inclusion criteria were as follows: patients needing THA; no history of THA; be able to tolerate anesthetics and surgery; no taking nonsteroid anti-inflammatory drugs or immunosuppressive drug within 4 weeks before surgery; no history of tumor; and no previous surgery in 3 months before surgery. On admission, all patients that met inclusion criteria were informed about the clinical study. They decided to be enrolled or not and signed the consent forms. Finally, 148 patients scheduled for unilateral THA were enrolled from August 2009 to March 2013.

All patients underwent the unilateral THA. All of the operations were performed by the same surgeon through the posterolateral approach to reduce the difference in surgical trauma. Each case received epidural anesthesia and a patient controlled epidural analgesia pump at the end of the operation.

Clinical assessment {#sec2-2}
-------------------

Harris score was used to assess hip function before surgery and at 3 days after surgery. The Numeric Rating Scale was used to help patients communicate how much pain they were experiencing at moving the operated limb. The measuring was conducted at the admission and at 3 days postoperatively. On the basis of scores, there were four grades: none (0), mild (1--3), moderate (4--6), and severe (7--10). Data, including age, gender, weight, and height, were collected upon admission. The surgery duration and the total blood loss and transfusion were also recorded. The incision length was measured with an aseptic paper ruler after suture.

Measurement of serum CRP and IL-6 levels {#sec2-3}
----------------------------------------

Blood samples were obtained preoperatively in the morning of the surgery and at 24 h, 48 h, and 72 h postoperatively. The CRP concentrations were determined using the latex particle-enhanced nephelometric immunoassay on the BN ProSpec analyzer (Dade Behring, Germany) and were expressed in mg/L. IL-6 was measured in serum samples by a sandwich quantitative enzyme immunoassay technique (R&D Systems, Camarillo, CA, USA). The assay had a sensitivity of 2--500 pg/ml for IL-6.

Calculation of estimated complication rates {#sec2-4}
-------------------------------------------

The modified physiological and operative severity score for the enumeration of the morbidity (POSSUM) was recorded pre- and intra-operatively\[[@ref9]\] \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\]. Based on the score, estimated complication rate was calculated according to the morbidity formula depicted by Mohamed *et al*.\[[@ref9]\] The morbidity (*R*) formula is as follows.

###### 

The physiological assessment in the orthopedic POSSUM system

  Items                          Physiological score                                                                            
  ------------------------------ --------------------- ----------------------------- ------------------------------------------ ---------------------------------------------------------------------------
  Age (years)                    \<60                  60--70                        \>70                                       \-
  Cardiac signs                  Normal                On cardiac drugs or steroid   Edema, warfarin, borderline cardiomegaly   Raised JVP Cardiomegaly
  Respiration signs              Normal                SOB exertion                  SOB stairs                                 SOB rest
  Chest radiograph               Normal                Mild COAD                     Model COAD                                 Any other chang (Fibrosis or consolidation)
  Systolic BP (mmHg)             110--130              130--170                      ≥171                                       ≤89
                                                       100--109                      90--99                                     
  Pulse (beats/min)              50--80                81--100                       100--120                                   ≥121
                                                       40--49                                                                   ≤39
  Coma score                     15                    12--14                        9--11                                      ≤8
  Blood urea (mmol/L)            ≤7.5                  7.6--10.0                     10.1--15.0                                 ≥15.1
  Blood Na (mmol/L)              ≥136                  131--135                      126--130                                   ≥125
  Blood K (mmol/L)               3.5--5.0              3.2--3.4                      2.9--3.1                                   ≥2.8
                                                       5.1--5.3                      5.4--5.9                                   ≥6
  Hb (g/dl)                      13--16                11.5--12.9                    10.0--11.4                                 ≤9.9
                                                       16.1--17.0                    17.1--18.0                                 ≥18.1
  White cell count (×10^12^/L)   4--10                 10.1--20.0                    ≥20.1                                      \-
                                                       3.1--3.9                      ≤3                                         
  ECG                            Normal                --                            Atrial fibrillation (rate 60--90)          Any other abnormal rhythm or ≥5 ectopics/min Q waves or ST/T wave changes

1 mmHg = 0.133 kPa. POSSUM: Physiological and operative severity score for the enumeration of the morbidity; BP: Blood pressure; Hb: Hemoglobin; ECG: Electrocardiograph; JVP: Jugular venous pressure; SOB: Shortness of breath; COAD: Chronic obstructive airway disease. - : Not applicable.

###### 

The operative severity assessment in the orthopedic POSSUM system

  Items                                          Operative severity score                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------
  Magnitude                                      Fasciotomy, ganglion/bursa, tenotomy/tendon repair, arthroscopic surgery, carpal tunnel/nerve release, removal of metal, closed reduction of fracture   Excision/osteotomy small bone, minor joint replacement, amputation digit/digits, closed reduction with external fixation, open reduction of fracture of small bone   Osteotomy long bone, Ligamentous reconstruction + prosthesis, arthrodesis large joint, major joint replacement, amputation limb, disc surgery, open reduction of fracture of a long bone   Radical tumorectomy, major spinal reconstruction, revision prosthetic replacement, major joint, hindquarter/forequarter amputation
  Number of operative variables within 30 days   1                                                                                                                                                       \-                                                                                                                                                                   2                                                                                                                                                                                          \>2
  Blood loss (ml)                                ≤100                                                                                                                                                    101--500                                                                                                                                                             501--999                                                                                                                                                                                   ≥1000
  Contamination                                  None                                                                                                                                                    Incised wound                                                                                                                                                        Minor contamination or necrosis tissue                                                                                                                                                     Gross contamination or necrosis tissue
  Presence of malignancy                         None                                                                                                                                                    Primary lesion                                                                                                                                                       Node metastases                                                                                                                                                                            Distant metastases
  Timing of operation                            Elective                                                                                                                                                \-                                                                                                                                                                   Emergency, resuscitation possible ≤48 h                                                                                                                                                    Emergency, immediate ≤6 h

-: Not applicable; POSSUM: Physiological and operative severity score for the enumeration of the morbidity.

ln *R*/(1 − *R*) = −5.91 + (0.16 × physiological score) + (0.19 × operative severity score).

Statistical analysis {#sec2-5}
--------------------

The statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS version 15.0 for Windows, SPSS Inc., Chicago, IL, USA). The data were expressed as mean ± standard deviation (SD) or as a percentage of patients. The changes of variables before and after surgery were compared using analysis of variance or *t*-tests. Correlation analysis was used to analyze relationships between variables. *P* \< 0.05 was considered statistically significant.

R[esults]{.smallcaps} {#sec1-3}
=====================

Totally, 148 patients enrolled and no one dropped out during hospitalization. The average time of hospital stay after surgery was 6.7 days. There were nine cases (6.08%) of intracapsular femoral neck fracture, 17 cases (11.49%) of intertrochanteric fracture, 11 cases (7.43%) of old femoral neck or intertrochanteric fracture, 72 cases (48.65%) of femoral head necrosis, 18 cases (12.16%) of hip dysplasia, 15 cases (10.14%) of hip osteoarthritis, three cases (2.03%) of hip rheumatoid arthritis, and three cases (2.03%) of ankylosing spondylitis. Before surgery, both CRP and IL-6 levels in patients of intracapsular neck fracture and intertrochanteric fracture were significantly higher than other group patients \[[Figure 1](#F1){ref-type="fig"}\]. [Table 3](#T3){ref-type="table"} summarizes the main population characteristics, including age, gender, body mass index (BMI), surgery duration, incision length, blood loss, and transfusion. Neither of these background variables had a significant correlation with CRP nor IL-6 peak levels after surgery.

![Preoperative serum CRP and IL-6 levels for different diseases. Both CRP and IL-6 levels in NF and IF groups are significantly higher than those in OF, HN, HD, and Ar groups (all *P* \< 0.05). CRP: C-reaction protein; IL-6: Interleukin-6; NF: Intracapsular femoral neck fracture; IF: Intertrochanteric fracture; OF: Old fracture; HN: Femoral head necrosis; HD: Hip dysplasia; Ar: Arthritis including hip osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.](CMJ-129-2546-g001){#F1}

###### 

Demographic characteristics, operative parameters, and their correlations with CRP and IL-6 levels (*n* = 148)

  Parameters               Values            CRP      IL-6            
  ------------------------ ----------------- -------- ------ -------- ------
  Age (years)              61.62 ± 15.35     0.140    0.64   0.165    0.85
  Male\*                   84 (56.76%)       −0.168   0.94   −0.273   0.82
  BMI (kg/m^2^)            25.31 ± 3.72      0.077    0.46   0.132    0.13
  Surgery duration (min)   91.66 ± 15.13     0.200    0.90   0.314    0.90
  Incision length (cm)     12.26 ± 2.39      0.066    094    0.089    0.73
  Blood loss (ml)          612.34 ± 220.64   0.193    0.76   0.199    0.94
  Blood transfusion (IU)   2.17 ± 1.39       0.097    0.84   0.112    0.97

All data are shown as mean ± SD or *n* (%) unless otherwise indicated. \*Spearman correlation coefficient test was used in correlation analysis. The others used Pearson correlation coefficient test. CRP: C-reaction protein; IL-6: Interleukin-6; BMI: Body mass index; SD: Standard deviation.

Before surgery, both IL-6 and CRP levels were lower. After surgery, both IL-6 and CRP levels rose immediately and reached the peak at 24 and 48 h, respectively. After that, both levels decreased. Both IL-6 and CRP levels at each time point after surgery were significantly higher than that before surgery (all *P* \< 0.05) \[[Figure 2](#F2){ref-type="fig"}\].

![Pre- and post-operative serum CRP and IL-6 levels. CRP: C-reaction protein; IL-6: Interleukin-6.](CMJ-129-2546-g002){#F2}

The mean Harris score was 41.62 ± 23.47 before surgery and 72.75 ± 9.13 at 3 days after surgery. There was a significant increase of Harris scores after surgery (*P* \< 0.001). The mean pain scores decreased significantly after surgery (5.46 ± 1.61), compared with that before surgery (6.90 ± 3.11, *P* = 0.012). The Harris scores after surgery did not have a significant relation with either IL-6 or CRP peak levels (*P* = 0.165, *P* = 0.341, respectively).

The average physiological score was 18.79 ± 4.93. The average operative severity score was 14.01 ± 2.86. The estimated complication rate was 43 cases of 148 patients. Actually, there were only 28 cases who were observed to get postoperative complications during hospitalization, including eight cases of pulmonary infection, five cases of wound infection, and 17 cases of digestive system diseases (five cases of diarrhea, five cases of abdominal distention, and seven cases of constipation). There were 2 cases with both pulmonary infection and digestive system diseases. Moreover, there was one case that got prosthesis-related infection and underwent debridement and two-stage revision surgery. There was no significant difference between estimated and observed complication rates (*P* = 0.078). In the group with complications, the CRP and IL-6 peak levels were significantly higher than those in the group without complications (both *P* \< 0.001) \[[Figure 3](#F3){ref-type="fig"}\]. The estimated complication rates for patients of intracapsular neck and intertrochanteric fracture were consistent with observed rates. As for patients of other diseases, the estimated rates were higher than the observed rates \[[Table 4](#T4){ref-type="table"}\].

![Comparisons of CRP and IL-6 peak levels after surgery between the group with complications and the group without complications. In the group with complications, the IL-6 (\*) and CRP (†) peak levels were significantly higher than those in the group without complications (both *P* \< 0.001). IL-6: Interleukin-6; CRP: C-reaction protein.](CMJ-129-2546-g003){#F3}

###### 

Physiological and operative severity scores, estimated and observed complication rates for different diseases (*n* = 148)

  Diseases                      Physiological score   Operative severity score   Complication rates   
  ----------------------------- --------------------- -------------------------- -------------------- ----
  Intracapsular neck fracture   19.01 ± 4.90          14.88 ± 3.01               4                    4
  Intertrochanteric fracture    19.90 ± 4.96          14.60 ± 2.84               7                    8
  Old fracture                  18.92 ± 4.28          13.69 ± 2.67               3                    2
  Head necrosis                 18.71 ± 4.96          14.00 ± 2.97               16                   10
  Hip dysplasia                 16.94 ± 3.51          13.03 ± 2.14               6                    2
  Arthritis                     17.95 ± 4.04          13.67 ± 2.88               7                    2

All data are shown as mean ± SD unless otherwise indicated. SD: Standard deviation.

The scatter diagrams of the correlations between both IL-6 and CRP peak levels and estimated complication rates showed linear trends \[[Figure 4](#F4){ref-type="fig"}\]. The Pearson correlation analysis resulted that there was a significant positive relationship between IL-6 peak levels and estimated complication rates (*r* = 0.558, *P* \< 0.001). A similar relationship could also be observed between CRP peak levels and estimated complication rates (*r* = 0.577, *P* \< 0.001). After multivariate linear regression analysis, the IL-6 variable was rejected out and a regression equation could be got as follows: Estimated complication rate = −4.037 + 0.064 × CRP (mg/L) (*P* \< 0.001).

![The scatter diagrams of the correlations between both IL-6 (a) and CRP (b) peak levels and estimated complication rates (*n* = 148). IL-6: Interleukin-6; CRP: C-reaction protein.](CMJ-129-2546-g004){#F4}

D[iscussion]{.smallcaps} {#sec1-4}
========================

In the present study, we estimated all patients' complication rates by the POSSUM scores before surgery and investigated the early inflammatory response in the first 3 days after THA. Results showed that there was a significantly positive relationship between the level of inflammatory response and estimated complication rate. There was no significant difference between estimated and observed complication rates. The CRP and IL-6 peak levels in the group with complications were significantly higher than those in the group without complications.

After THA, previous reports describe that circulating concentration of IL-6 significantly increases, which concurs with our findings. Moreover, IL-6 can regulate the generation of the acute-phase response, including CRP. Consistent with the present study, many studies show that the increase in IL-6 is followed by a rise in CRP in patients who undergo THA. Moreover, there is usually a significant relationship between both markers.\[[@ref2]\] Besides, the releases of IL-6 and CRP correlate with the severity of tissue trauma. Therefore, in many studies, IL-6 or CRP is detected as the marker of surgery magnitude.\[[@ref10]\] Many previous studies have been performed to evaluate the postoperative inflammatory response, adopting IL-6 and CRP as the markers.\[[@ref11]\] Hall *et al*.\[[@ref11]\] studied the relationship between hip functional recovery and inflammatory response after hip arthroplasty and suggested that the inflammatory response was correlative with postoperative pain and early functional recovery. In the study of Feng *et al*.,\[[@ref12]\] patients undergoing elective total knee replacement were investigated and it was found that peripheral IL-6 level significantly correlated with pain score at 48 h after surgery. Besides, Ugras *et al*.\[[@ref13]\] found that early functional recovery after total knee replacement was affected by the local inflammatory response. However, in this study, the early functional recovery did not significantly correlate with either IL-6 or CRP levels. This might be because our study has a small sample and the functional scores at 3 days after surgery are too early to be distinguished.

Furthermore, many researchers have observed that IL-6 and CRP are useful risk factors and indicators of infectious complications. Scherer *et al*.\[[@ref14]\] studied 330 patients who had operative fracture treatment and suggested that a cutoff CRP level of 140 mg/L on the 4^th^ day after surgery was recorded for patients with deep wound infection. This evidence suggested that inflammatory response more or less gave a prediction for the incidence of complications. However, these results did not clearly prove the relationship between inflammatory response and the morbidity of complications after THA. In this study, we correlated the level of inflammatory response with estimated complication rate by POSSUM and found there was a significantly positive relationship between them, which was in accordance with previous results. Moreover, the CRP and IL-6 peak levels in the group with complications were significantly higher than those in the group without complications, which additionally noted the predictive role of inflammatory response.

The POSSUM system was first depicted by Copeland as a measurable method of assessing outcomes of surgical intervention based on symptoms and signs, physiological parameters, and operative severity parameters.\[[@ref15]\] Mohamed *et al*.\[[@ref9]\] modified the score system and made it applicable in orthopedic surgeries. They applied the modified POSSUM in a study of 2336 cases who underwent orthopedic surgeries and found that the estimated morbidity and mortality were nearly the same with the observed rates.\[[@ref9]\] In our study, we calculated the estimated complication rate by POSSUM and analyzed its correlation with the level of inflammatory response. Our results showed that the estimated complication rates were consistent with the observed rates, indicating the applicability of the modified POSSUM in orthopedic surgeries.

Some previous studies observed that the levels of CRP and IL-6 were relative with age,\[[@ref16]\] gender,\[[@ref17]\] BMI,\[[@ref18]\] the total blood loss\[[@ref19][@ref20]\] or transfusion,\[[@ref21]\] or postoperative pain.\[[@ref12]\] However, in this study, there were no significant relationships between these background variables and CRP or IL-6 levels. This might be because the relationship is so weak that it is not significant in a small-sample study. Several other limitations of the study should also be acknowledged. First, the main limitation of the present study is a small size and heterogeneous character of patient population. There are some confounding factors that might have an influence on levels of CRP and IL-6 after surgery. However, the inclusion criteria are so strict that the investigation is too time consuming to find a lager enough patient population. Second, it would be better if the drained fluid samples were collected to detect local inflammatory factors. As reported in a previous study,\[[@ref22][@ref23]\] there was a 1000-fold increase of IL-6 levels in drained fluid, comparing to the systemic concentrations in arterial blood of patients operated in thoracic scoliosis. Furthermore, what period of complications after surgery the CRP and IL-6 levels could predict is still unclear. The answer cannot be gotten in this study, either. More attention should be given on this problem in further studies.

In conclusion, we concluded that the early inflammatory response significantly correlated with the estimated complication rate and it could give predictions for complications after THA.
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